In addition, activated ESR1 stimulates the expression of tumor promoters and promotes colon cancer cell survival and metastasis; thus, blocking ESR1 expression offers a potential therapeutic opportunity for colon cancer [76]. This evidence concerns the gene ESR1 and malignant colon neoplasm.